News

Cephalon, a wholly owned subsidiary of Teva Pharmaceutical Industries, will market the product. Provigil will continue to be manufactured under the brand product’s NDA at the same facility

The Phase III investigational study did not meet the primary endpoint in reducing the rate of recurrence of diverticulitis over a two-year treatment period. The SPD476, MMX mesalamine

The supplements are formulated to compliment bioidentical hormone therapies and other individualized healthcare needs. All supplements are specialized, pharmaceutical grade, ensuring that the dosages and ingredients listed on

Rosuvastatin is a HMG-COA Reductase Inhibitor (cholesterol-lowering medication). RPCI, a wholly owned subsidiary of Ranbaxy Laboratories, sells and distributes generic prescription products in the Canadian healthcare system. RPCI

The company has begun the shipment of anti-cholesterol drugs, atorvastatin calcium oral tablets, which will be produced at its Mohali SEZ plant in Punjab, the Business Standard reported.

The new AED40m ($10.8m) manufacturing facility will mark the company’s expansion into growing regional pharmaceutical markets while signalling the first pharmaceutical production unit at DuBiotech. The90,000ft² facility is

Raptor has appealed for priority review of the NDA, which, if granted, could lead to a decision for marketing approval of RP103 in the fourth calendar quarter of

The partnership is aimed at identifying biomarkers that may lead to the development of a molecular companion diagnostic test to help identify patients likely to respond to a

Threshold is presently testing TH-302 along with a commonly used chemotherapeutic agent, doxorubicin, in a late-stage trial to treat soft tissue sarcoma. The orphan status can provide a